RecruitingNCT01808937
Rare condition
Localized scleroderma
5
studies recruiting now
as of 7 Sept 2026
36
studies registered in total
as of 7 Sept 2026
3
countries with a recruiting site
as of 7 Sept 2026
18 Dec 2025
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNot applicableNCT07292961
Investigating the Effectiveness of the Biopsychosocial Model-Based Exercise Approach in Children and Adults Diagnosed With Scleroderma
RecruitingNCT07183072
Patients Diagnosed With Scleroderma: Physical Performance and Functionality
RecruitingNCT07182981
Patients Diagnosed With Scleroderma and Their Chewing and Swallowing Performance
RecruitingNCT04095351
Connective Tissue Diseases and Lung Manifestations
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
Search all Localized scleroderma studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Localized scleroderma study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Localized scleroderma
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
20 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 3Sodium Chloride (Aqsia (balanced salt soln))
Phase 3Cyclophosphamide (Cyclophosphamide)
Phase 3Onabotulinumtoxina (Botox/botox cosmetic)
Phase 2/3Lidocaine (Alphacaine)
Phase 2Atorvastatin (Cardyl)
Phase 2Riociguat (Adempas)
Phase 2Imatinib Mesylate (Gleevec)
Phase 2Serelaxin
+ 12 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).